Abstract
Aims: Hepatogenous diabetes (HD) is frequently prevalent in liver cirrhosis (LC) and represents an important prognostic risk factor for decreased long-term survival and an increased rate of several complications. However, investigations of current practice concerning treatment are extremely sparse.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
